Cinctive Capital Management LP Has $10.98 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Cinctive Capital Management LP trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 58.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,359 shares of the medical equipment provider’s stock after selling 31,797 shares during the period. Cinctive Capital Management LP’s holdings in Intuitive Surgical were worth $10,984,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. FMR LLC lifted its stake in Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Fisher Asset Management LLC boosted its position in Intuitive Surgical by 1.8% during the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock worth $2,349,441,000 after purchasing an additional 86,208 shares during the period. Baillie Gifford & Co. increased its holdings in shares of Intuitive Surgical by 0.6% in the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after purchasing an additional 24,183 shares during the last quarter. American Century Companies Inc. raised its position in shares of Intuitive Surgical by 3.0% in the second quarter. American Century Companies Inc. now owns 2,398,193 shares of the medical equipment provider’s stock valued at $1,066,837,000 after purchasing an additional 70,556 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of Intuitive Surgical by 1.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,227,467 shares of the medical equipment provider’s stock worth $1,094,288,000 after buying an additional 28,703 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Amy L. Ladd sold 450 shares of the firm’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares in the company, valued at $402,519.88. This trade represents a 35.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 50,459 shares of company stock valued at $26,080,251. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Stock Up 0.6 %

Shares of NASDAQ:ISRG opened at $542.00 on Monday. The firm has a market cap of $193.05 billion, a P/E ratio of 87.14, a P/E/G ratio of 5.33 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $304.50 and a 12-month high of $552.00. The business has a fifty day simple moving average of $510.03 and a 200 day simple moving average of $469.49.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Analysts Set New Price Targets

Several research analysts have weighed in on ISRG shares. Mizuho increased their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. Piper Sandler reissued an “overweight” rating and issued a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Leerink Partners increased their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $536.61.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.